loader image
Friday, November 28, 2025
71.2 F
McAllen
- Advertisement -

U.S. Overdose Deaths Decrease in 2023

Health & Lifestyle
262

Listen to article (english)

Translate to Spanish or other 102 languages!

There were an estimated 107,543 overdose deaths in the United States in 2023, according to the CDC. 111,029 deaths were reported in 2022.  Image for illustration purposes
There were an estimated 107,543 overdose deaths in the United States in 2023, according to the CDC. 111,029 deaths were reported in 2022.  Image for illustration purposes

Mega Doctor News

- Advertisement -

Newswise — According to the Centers for Disease Control, preliminary data shows drug overdose deaths decreased by three percent in 2023. This would be the first annual decrease in drug overdose deaths since 2018. 

There were an estimated 107,543 overdose deaths in the United States in 2023, according to the CDC. 111,029 deaths were reported in 2022. 

Nebraska, Kansas, Indiana and Maine saw decreases of more than 15 percent. 

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Pioneering gene therapy restores deaf toddler’s hearing
Next article
Surprising Health Benefits of Pickles

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© Mega Doctor News 2025

×